SIRTEX MEDICAL INC

SIRTEX MEDICAL INC specializes in the manufacturing and supply of targeted radiopharmaceutical therapies and precision irradiation devices for clinical use in oncology. The company’s core capabilities center on the production of yttrium-90 (Y-90) resin microspheres and associated delivery systems used in selective internal radiation therapy (SIRT), a minimally invasive treatment for liver cancers. Their technical expertise includes radiopharmaceutical formulation, sterile manufacturing under GMP conditions, radiation safety protocols, and the integration of specialized delivery hardware for controlled radionuclide administration. Key differentiators include end-to-end control over the production chain—from isotope incorporation to final sterile packaging—and the ability to deliver time-sensitive, clinically critical doses under emergency and routine operational conditions. SIRTEX maintains a strong, consistent relationship with the Department of Veterans Affairs and the Department of Defense, providing life-saving radiopharmaceuticals and irradiation equipment to support veteran and military healthcare programs. For the VA, the company delivers routine and emergency shipments of Y-90 microspheres and accessory kits used in interventional radiology suites. The DoD relies on SIRTEX for specialized radiation therapy devices and bulk supply agreements, indicating a trusted partnership in operational medical readiness. The company’s primary industry focus is in pharmaceutical preparation manufacturing (NAICS 325412), with secondary expertise in irradiation apparatus manufacturing (334517) and surgical appliance production (339113). This positions SIRTEX as a niche provider in the nuclear medicine and targeted radiotherapy market, serving hospitals and clinical centers requiring certified, on-demand radiopharmaceutical solutions. SIRTEX MEDICAL INC is a small business entity headquartered in Woburn, Massachusetts, with no federal certifications listed. Its government market presence is defined by direct, mission-critical supply contracts rather than broad procurement frameworks, reflecting a focused, high-reliability role in specialized medical defense and veteran care systems.